Ameriprise Financial Inc Pro Phase Labs, Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$7.15 - $9.78 $30,573 - $41,819	4,276 Added 4.83%	92,729 $673,000
Q4 2022 Feb 14, 2023	SELL	$8.78 - $12.47 $9,087 - $12,906	-1,035 Reduced 1.16%	88,453 $851,000
Q3 2022 Nov 14, 2022	SELL	$8.96 - $14.7 $421,532 - $691,576	-47,046 Reduced 34.46%	89,488 $1.01 Million
Q2 2022 Aug 15, 2022	SELL	$6.52 - $13.24 $9,193 - $18,668	-1,410 Reduced 1.02%	136,534 $1.73 Million
Q1 2022 May 16, 2022	BUY	$6.2 - $7.87 $20,416 - $25,915	3,293 Added 2.45%	137,944 $965,000
Q4 2021 Feb 14, 2022	BUY	$5.13 - $7.89 $690,759 - $1.06 Million	134,651 New	134,651 $964,000

1.7M

500

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $38.5M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.